JMI LABS IS NOW PART OF LEARN MORE

Filter by Event: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017

Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Contemporary (2014-2016) P. aeruginosa Isolates from Hospitalized Patients with Bloodstream Infections and Pneumonia in European Medical Centres

Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Contemporary (2014-2016) P. aeruginosa Isolates from Hospitalized Patients with Bloodstream Infections and Pneumonia in European Medical Centres. Lead author: D Shortridge, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1246

Telavancin Activity against a Global Collection of Staphylococcus aureus Clinical Isolates (2013-2015)

Telavancin Activity against a Global Collection of Staphylococcus aureus Clinical Isolates (2013-2015). Lead author: RE Mendes, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1356

β-lactamase Characterization of Baseline Gram-Negative Pathogens from a Phase 3 Trial of Ceftazidime-Avibactam (CAZ-AVI) for the Treatment of Nosocomial Pneumonia

β-lactamase Characterization of Baseline Gram-Negative Pathogens from a Phase 3 Trial of Ceftazidime-Avibactam (CAZ-AVI) for the Treatment of Nosocomial Pneumonia. Lead author: RE Mendes, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P0408

Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Contemporary (2014-2016) Gram-Negative Organisms Collected from European Medical Centres

Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Contemporary (2014-2016) Gram-Negative Organisms Collected from European Medical Centres. Lead author: D Shortridge, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1271

Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Contemporary (2014-2016) Gram-Negative Organisms Collected from Latin America Medical Centres

Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Contemporary (2014-2016) Gram-Negative Organisms Collected from Latin America Medical Centres. Lead author: LR Duncan, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1272

Dalbavancin Tested against Staphylococcus aureus Isolates with Decreased Susceptibility to Glycopeptides and/or Lipopeptides from European Hospitals (2012-2016)

Dalbavancin Tested against Staphylococcus aureus Isolates with Decreased Susceptibility to Glycopeptides and/or Lipopeptides from European Hospitals (2012-2016). Lead author: RE Mendes, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna Austria
# P0138

Activity of Tedizolid against Methicillin-Susceptible and -Resistant Staphylococcus aureus Pathogens Isolated from Patients in European Centres and Surrounding Regions

Activity of Tedizolid against Methicillin-Susceptible and -Resistant Staphylococcus aureus Pathogens Isolated from Patients in European Centres and Surrounding Regions. Lead author: RE Mendes, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1344

Activity of Tedizolid against Gram-Positive Clinical Isolates Causing Infections in Europe and Surrounding Areas (2014-2015)

Activity of Tedizolid against Gram-Positive Clinical Isolates Causing Infections in Europe and Surrounding Areas (2014-2015). Lead author: RE Mendes, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1502

Plazomicin Activity against European Enterobacteriaceae Isolates Carrying Aminoglycoside-Modifying Enzymes and 16S rRNA Methylases

Plazomicin Activity against European Enterobacteriaceae Isolates Carrying Aminoglycoside-Modifying Enzymes and 16S rRNA Methylases. Lead author: M Castanheira, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1281

In vitro Activity of Omadacycline and Comparators against Staphylococci, and Enterococci (including resistant organism subsets) from Patients in European medical Centres during 2016: Results from the SENTRY Antimicrobial Surveillance Program

In vitro Activity of Omadacycline and Comparators against Staphylococci, and Enterococci (including resistant organism subsets) from Patients in European medical Centres during 2016: Results from the SENTRY Antimicrobial Surveillance Program. Lead author: MD Huband, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1262

In vitro Activity of Omadacycline and Comparators against Gram-Negative Bacterial Isolates Collected from Patients in European Medical Centres (2016): Results from the SENTRY Antimicrobial Surveillance Program

In vitro Activity of Omadacycline and Comparators against Gram-Negative Bacterial Isolates Collected from Patients in European Medical Centres (2016): Results from the SENTRY Antimicrobial Surveillance Program. Lead author: MD Huband, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1253

Meropenem-Vaborbactam Activity against Enterobacteriaceae Isolates Collected during 2014-2015 from European Countries

Meropenem-Vaborbactam Activity against Enterobacteriaceae Isolates Collected during 2014-2015 from European Countries. Lead author: M Castanheira, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1286

Monitoring Echinocandin and Azole Susceptibility in a Global Collection of Invasive Fungal Isolates

Monitoring Echinocandin and Azole Susceptibility in a Global Collection of Invasive Fungal Isolates. Lead author: M Castanheira, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, 2017, Vienna, Austria
# P1748

In vitro Evaluation of Delafloxacin Activity When Tested against Contemporary ABSSSI Isolates from Europe and Surrounding Areas (2014-2016): Results from the SENTRY Antimicrobial Surveillance Program

In vitro Evaluation of Delafloxacin Activity When Tested against Contemporary ABSSSI Isolates from Europe and Surrounding Areas (2014-2016): Results from the SENTRY Antimicrobial Surveillance Program. Lead author: MD Huband, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1351

Dalbavancin Tested against Staphylococcus aureus Isolates with Decreased Susceptibility to Glycopeptides and/or Lipopeptides from European Hospitals (2012-2016)

Dalbavancin Tested against Staphylococcus aureus Isolates with Decreased Susceptibility to Glycopeptides and/or Lipopeptides from European Hospitals (2012-2016). Lead author: RE Mendes, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, 2017, Vienna, Austria
# P0138

Antimicrobial Activity of Ceftobiprole versus Other Currently Marketed Cephalosporins and β-Lactams When Tested against Contemporary Gram-Positive and -Negative Organisms Collected from Europe (2015)

Antimicrobial Activity of Ceftobiprole versus Other Currently Marketed Cephalosporins and β-Lactams When Tested against Contemporary Gram-Positive and -Negative Organisms Collected from Europe (2015). Lead author: RK Flamm, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P0146

Antimicrobial Activity of Ceftazidime-Avibactam Tested against Contemporary (2013-2015) Gram-Negative Organisms Collected from United States Medical Centers

Antimicrobial Activity of Ceftazidime-Avibactam Tested against Contemporary (2013-2015) Gram-Negative Organisms Collected from United States Medical Centers. Lead author: HS Sader, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna, Austria
# P1291

Activity of Plazomicin and Comparator Agents Tested against Recent Clinical Isolates Collected in Asia-Pacific, Europe, and Latin America

Activity of Plazomicin and Comparator Agents Tested against Recent Clinical Isolates Collected in Asia-Pacific, Europe, and Latin America. Lead author:M Castanheira, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, 2017, Vienna, Austria
# P1280